Fernandez-Salguero P - Search Results

1

Correlation between catalytic activity and protein content for the polymorphically expressed dihydropyrimidine dehydrogenase in human lymphocytes.

Fernandez-Salguero P, Gonzalez FJ, Etienne MC, Milano G, Kimura S. Fernandez-Salguero P, et al. Biochem Pharmacol. 1995 Sep 28;50(7):1015-20. doi: 10.1016/0006-2952(95)00231-n. Biochem Pharmacol. 1995. PMID: 7575656

2

Fitting a xenobiotic receptor into cell homeostasis: how the dioxin receptor interacts with TGFbeta signaling.

Gomez-Duran A, Carvajal-Gonzalez JM, Mulero-Navarro S, Santiago-Josefat B, Puga A, Fernandez-Salguero PM. Gomez-Duran A, et al. Biochem Pharmacol. 2009 Feb 15;77(4):700-12. doi: 10.1016/j.bcp.2008.08.032. Epub 2008 Sep 5. Biochem Pharmacol. 2009. PMID: 18812170 Review.

3

The antiproliferative activity of resveratrol results in apoptosis in MCF-7 but not in MDA-MB-231 human breast cancer cells: cell-specific alteration of the cell cycle.

Pozo-Guisado E, Alvarez-Barrientos A, Mulero-Navarro S, Santiago-Josefat B, Fernandez-Salguero PM. Pozo-Guisado E, et al. Biochem Pharmacol. 2002 Nov 1;64(9):1375-86. doi: 10.1016/s0006-2952(02)01296-0. Biochem Pharmacol. 2002. PMID: 12392819

4

Dihydropyrimidine dehydrogenase pharmacogenetics in patients with colorectal cancer.

Ridge SA, Sludden J, Wei X, Sapone A, Brown O, Hardy S, Canney P, Fernandez-Salguero P, Gonzalez FJ, Cassidy J, McLeod HL. Ridge SA, et al. Br J Cancer. 1998;77(3):497-500. doi: 10.1038/bjc.1998.79. Br J Cancer. 1998. PMID: 9472650 Free PMC article.

5

cDNA cloning and chromosome mapping of human dihydropyrimidine dehydrogenase, an enzyme associated with 5-fluorouracil toxicity and congenital thymine uraciluria.

Yokota H, Fernandez-Salguero P, Furuya H, Lin K, McBride OW, Podschun B, Schnackerz KD, Gonzalez FJ. Yokota H, et al. J Biol Chem. 1994 Sep 16;269(37):23192-6. J Biol Chem. 1994. PMID: 8083224

6

Lack of correlation between phenotype and genotype for the polymorphically expressed dihydropyrimidine dehydrogenase in a family of Pakistani origin.

Fernandez-Salguero PM, Sapone A, Wei X, Holt JR, Jones S, Idle JR, Gonzalez FJ. Fernandez-Salguero PM, et al. Pharmacogenetics. 1997 Apr;7(2):161-3. doi: 10.1097/00008571-199704000-00012. Pharmacogenetics. 1997. PMID: 9170156

7

Dihydropyrimidine dehydrogenase pharmacogenetics in Caucasian subjects.

Ridge SA, Sludden J, Brown O, Robertson L, Wei X, Sapone A, Fernandez-Salguero PM, Gonzalez FJ, Vreken P, van Kuilenburg AB, van Gennip AH, McLeod HL. Ridge SA, et al. Br J Clin Pharmacol. 1998 Aug;46(2):151-6. doi: 10.1046/j.1365-2125.1998.00751.x. Br J Clin Pharmacol. 1998. PMID: 9723824 Free PMC article.

8

Effect of phenobarbital on hepatic CYP1A1 and CYP1A2 in the Ahr-null mouse.

Zaher H, Yang TJ, Gelboin HV, Fernandez-Salguero P, Gonzalez FJ. Zaher H, et al. Biochem Pharmacol. 1998 Jan 15;55(2):235-8. doi: 10.1016/s0006-2952(97)00476-0. Biochem Pharmacol. 1998. PMID: 9448747

9

Characterization of the human dihydropyrimidine dehydrogenase gene.

Wei X, Elizondo G, Sapone A, McLeod HL, Raunio H, Fernandez-Salguero P, Gonzalez FJ. Wei X, et al. Genomics. 1998 Aug 1;51(3):391-400. doi: 10.1006/geno.1998.5379. Genomics. 1998. PMID: 9721209

10

Molecular basis of the human dihydropyrimidine dehydrogenase deficiency and 5-fluorouracil toxicity.

Wei X, McLeod HL, McMurrough J, Gonzalez FJ, Fernandez-Salguero P. Wei X, et al. J Clin Invest. 1996 Aug 1;98(3):610-5. doi: 10.1172/JCI118830. J Clin Invest. 1996. PMID: 8698850 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results